Welcome to PERMEPSY
International project dedicated to establishing a personalized approach to psychological treatment for psychosis.
About project
PERMEPSY is a three-year project coordinated by the Parc Sanitari Sant Joan de Déu composed of 5 clinical partners from 5 different countries (Spain, Germany, France, Poland, and Chile) and one technological team (Spain). The aim of PERMEPSY (Personalised Medicine approach to psychological treatment for Psychosis) is to offer personalised delivery of Metacognitive Training (MCT) for people with psychosis.
Research team
Our consortium relies on a multidisciplinary team that includes experts in clinical psychology, psychiatry, computer science and artificial intelligence, molecular biology, and statistics. The clinical partners (coordinators FJSD, and partners UKE, UHS, PAoS, and UV) have collaborated throughout the years to develop MCT strategies addressed to patients with psychosis in different stages of the disorder.
Updates
You will find updates here about our project. If you want to stay up-to-date, join our newsletter.
🔬 New PERMEPSY Publication in European Psychiatric Association
We’re thrilled to share our latest open-access article: “MCT for psychosis: a systematic review and GRADE recommendations”🔗 Read here This work, led by the French
🎓 PERMEPSY at EABCT 2025 – Sharing New Insights on #MCT
We’re excited to share that our team was present at the EABCT Conference 2025 in #Glasgow, where Hanna Gelner presented a poster based on our newly
🎥 Support PERMEPSY: Vote for our video!
The PERMEPSY team is proud to take part in the EP PerMed – the European Partnership for Personalised Medicine video competition! 👥 Huge thanks to